“…However, because of its complex nature and risk of adverse reactions such as vasospasm and limb ischemia, it is currently only used as a backup plan in cases of severe shock, acute blood loss, near-death state, and clinical death. [6,17,27] In this study, during the process of preparing the hemorrhagic shock model, the average blood loss of the experimental animals was 25 mL/kg, and MAP decreased to 50% of the baseline value and stabilized at approximately 50 mmHg. MAP, pulse pressure, urine output, and blood lactate levels showed significant changes, indicating that the model met the requirements and was accurate.…”